The Cooper Companies, Inc.
In the published model solve dated 2026-Q2, anchored at $71.17, The Cooper Companies, Inc. (COO) is priced for today's economics sustained for ~5.7 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Cooper is two companies sharing a ticker: CooperVision sells contact lenses and brought in $723.5 million of revenue last quarter, split almost evenly between plain corrective lenses and the higher-priced toric and multifocal designs, while CooperSurgical serves fertility and women's health at $358.0 million. • The single biggest number in the recent file is legal: $271.6 million of litigation expense, net of insurance recoveries, booked in one quarter to resolve claims tied to the recall of C
Is COO overvalued? See what's priced in →
654 institutional managers reported holding COO in 13F filings for the quarter ended 2026-03-31. 90 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 7.3M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (1.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
COO has cut its share count 1.1% over the past five years, spending $476.60M on repurchases. It pays no dividend. Cash returned over the past three years: $398.10M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at COO over the trailing three years: 2025: 10 buys totaling $2.52M. 15 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
COO's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-06-03 | -4.0% | +9.1% |
| 2023-09-01 | -2.1% | -8.2% |
| 2023-12-09 | -2.2% | +12.4% |
| 2024-03-02 | +8.1% | -11.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
COO's latest 8-K filings: 2026-06-04 (items 2.02, 8.01, 9.01); 2026-05-04 (items 5.02); 2026-04-08 (items 5.07); 2026-03-05 (items 2.02, 9.01); 2026-02-04 (items 1.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.